Health By Nicholas Florko ‘Too little too late’: Unpacking Biden’s moves to improve federal prisons’ response to Covid-19
Politics By Lev Facher Francis Collins: Concern about independence of new moonshot science agency ARPA-H are ‘overblown’
Politics By Rachel Cohrs Biden administration won’t lower seniors’ Medicare premiums this year, despite changes to coverage of new Alzheimer’s drug
D.C. Diagnosis By Nicholas Florko As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms
Politics By Lev Facher The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years
Exclusive By Rachel Cohrs Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb
Hospitals By Tara Bannow The FTC says it’s getting tougher on hospital consolidation. Antitrust experts aren’t buying it
Exclusive By Nicholas Florko Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs
Exclusive By Rachel Cohrs White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process
Politics By Lev Facher A new nonprofit wants to rewrite the playbook for how the U.S. government funds science
Politics By Lev Facher Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on
Politics By Rachel Cohrs Medicare finalizes its restrictions on new Alzheimer’s drug, despite pressure from drugmakers
Politics By Rachel Cohrs Biden administration ramps up long Covid research efforts following criticism
Exclusive By Lev Facher Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist
Politics By Rachel Cohrs CMMI’s Fowler on health policy’s ‘stubborn challenges,’ her personal ties to medicine
Exclusive By Lev Facher Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence
Politics By Rachel Cohrs ‘A slow-moving glacier’: NIH’s sluggish and often opaque efforts to study long Covid draw patient, expert ire
Special Report By Lev Facher NIH’s identity crisis: The pandemic and the search for a new leader leave the agency at a crossroads
Politics By Lev Facher and Damian Garde The new White House Covid coordinator is great on TV. Is that what America’s pandemic response needs now?
Politics By Nicholas Florko Lawmakers face off about the future of the FDA’s accelerated approval pathway
Health By Andrew Marquardt — Medill News Service Doctors, companies push to keep looser, pandemic-era rules for prescribing opioid addiction treatment via telemedicine
Special Report By Rachel Cohrs Why formally ending the pandemic is going to be a huge headache for the entire health care system